Squalene: Current knowledge and potential therapeutical uses

Squalene: Current Knowledge and Potential Therapeutical Uses

Volumn , Issue , 2011, Pages 1-73

  Ramirez Torres A ^a   Gabas C ^a   Barranquero, C ^a   Martinez Beamonte R ^a   Fernandez Juan M ^a   Navarro, M A ^a   Guillen N ^a   Lou Bonafonte, J M ^a   Arnal, C ^a   Martinez Gracia M V ^a   Osada, J ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892089895     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (217)

1. Zadak Z, Hyspler R, Ticha A, Solichova D, Blaha V, Melichar B. Polyunsaturated fatty acids, phytosterols and cholesterol metabolism in the Mediterranean diet. Acta Medica. (Hradec Kralove). 2006;49(1):23-6.
2. Keys A. Mediterranean diet and public health: personal reflections. Am. J. Clin. Nutr. 1995;61:1321S-3S.
3. Keys A, Menotti A, Karvonen MJ. The diet and 15-year death rate in the Seven Countries Study. Am. J. Epidemiol. 1986;124:903-15.
4. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction. Circulation. 1999;99:779-85.
5. Ortega RM. Importance of functional foods in the Mediterranean diet. Public Health Nutr. 2006 Dec;9(8A):1136-40.
6. Wahrburg U, Kratz M, Cullen P. Mediterranean diet, olive oil and health. Eur. J. Lipid. Sci. Technol. 2002;104:698-705.
7. Waterman E, Lockwood B. Active components and clinical applications of olive oil. Altern. Med. Rev. 2007 Dec;12(4):331-42.
8. Pérez-Martínez P, López-Miranda J, Delgado-Lista J, López-Segura F, Pérez-Jiménez F. Aceite de oliva y prevención cardiovascular: más que una grasa. Clin. Invest. Arterioscl. 2006;18:195-205.
9. Stark AH, Madar Z. Olive oil as a functional food: epidemiology and nutritional approaches. Nutr. Rev. 2002 Jun;60(6):170-6.
10. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H. Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene. Food Chem. Toxicol. 2000 Aug;38(8):647-59.
11. Visioli F, Galli C. Biological properties of olive oil phytochemicals. Crit. Rev. Food Sci. Nutr. 2002;42(3):209-21.
12. Arbonés-Mainar JM, Navarro MA, Lou-Bonafonte JM, Martínez-Gracia MV, Osada J. Olive oil phenolic compounds as potential therapeutical agents. Vasallo N, editor. La Veletta: Nova; 2008.
13. Gutfinger J, Letan L. Studies of unsaponifiables in several vegetable oils. Lipids magazine. 1974;9:658.
14. Perona JS, Cabello-Moruno R, Ruiz-Gutierrez V. The role of virgin olive oil components in the modulation of endothelial function. J. Nutr. Biochem. 2006 Jul;17(7):429-45.
15. Murkovic M, Lechner S, Pietzka A, Bratacos M, Katzogiannos E. Analysis of minor components in olive oil. J. Biochem. Biophys. Methods. 2004 Oct 29;61(1-2):155-60.
16. Uceda M, Hermoso M. La calidad del aceite de oliva. In: Barranco D, Fernández-Escobar R, Rallo L, editors. El cultivo del olivo. 3 ed. Madrid: Ediciones Mundi-Prensa; 1999. p. 572-96.
17. Allouche Y, Jimenez A, Gaforio JJ, Uceda M, Beltran G. How heating affects extra virgin olive oil quality indexes and chemical composition. J. Agric Food Chem. 2007 Nov 14;55(23):9646-54.
18. Newmark HL. Is oleic acid or squalene the important preventive agent? Am. J. Clin. Nutr. 2000 Aug;72(2):502.
19. Smith TJ. Squalene: potential chemopreventive agent. Expert Opin. Investig. Drugs. 2000 Aug;9(8):1841-8.
20. Liu GC, Ahrens EH, Jr., Schreibman PH, Crouse JR. Measurement of squalene in human tissues and plasma: validation and application. J. Lipid Res. 1976 Jan;17(1):38-45.
21. Bakes MJ, Nichols PD. Lipid, fatty acid and squalene composition of liver oil from six species of deep-sea sharks collected in southern Australian waters. Comp. Biochem. Physiol. 1995;110(1):267-75.
22. He HP, Cai Y, Sun M, Corke H. Extraction and purification of squalene from amaranthus grain. J. Agric Food Chem. 2002 Jan 16;50(2):368-72.
23. Khallouki F, Younos C, Soulimani R, Oster T, Charrouf Z, Spiegelhalder B, et al. Consumption of argan oil (Morocco) with its unique profile of fatty acids, tocopherols, squalene, sterols and phenolic compounds should confer valuable cancer chemopreventive effects. Eur. J. Cancer Prev. 2003 Feb;12(1):67-75.
24. Connolly JD, Hill RA. Triterpenoids. Nat. Prod. Rep. 2008 Aug;25(4):794-830.
25. Li Q, Chen GQ, Fan KW, Lu FP, Aki T, Jiang Y. Screening and Characterization of Squalene-Producing Thraustochytrids from Hong Kong Mangroves. J. Agric Food Chem. 2009;57:4267-72.
26. Channon HJ. The Biological Significance of the Unsaponifiable Matter of Oils: Experiments with the Unsaturated Hydrocarbon, Squalene (Spinacene). Biochem. J. 1926;20(2):400-8.
27. Reddy LH, Couvreur P. Squalene: A natural triterpene for use in disease management and therapy. Adv. Drug Deliv. Rev. 2009 Oct 2.
28. Bosak T, Losick RM, Pearson A. A polycyclic terpenoid that alleviates oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2008 May 6;105(18):6725-9.
29. Owen RW, Giacosa A, Hull WE, Haubner R, Wurtele G, Spiegelhalder B, et al. Olive-oil consumption and health: the possible role of antioxidants. Lancet Oncol. 2000 Oct;1:107-12.
30. Wei A, Shibamoto T. Antioxidant activities and volatile constituents of various essential oils. J. Agric Food Chem. 2007 Mar 7;55(5):1737-42.
31. Kelly GS. Squalene and its potential clinical uses. Altern. Med. Rev. 1999 Feb;4(1):29-36.
32. Buddhan S, Sivakumar R, Dhandapani N, Ganesan B, Anandan R. Protective effect of dietary squalene supplementation on mitochondrial function in liver of aged rats. Prostaglandins Leukot. Essent. Fatty Acids. 2007 Jun;76(6):349-55.
33. Yasunari K, Maeda K, Minami M, Yoshikawa J. HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2001 Jun;21(6):937-42.
34. Moreno JJ. Effect of olive oil minor components on oxidative stress and arachidonic acid mobilization and metabolism by macrophages RAW 264.7. Free Radic Biol. Med. 2003 Nov 1;35(9):1073-81.
35. Acin S, Navarro MA, Perona JS, Arbones-Mainar JM, Surra JC, Guzman MA, et al. Olive oil preparation determines the atherosclerotic protection in apolipoprotein E knockout mice. J. Nutr. Biochem. 2007 Jun;18(6):418-24.
36. Mateos R, Dominguez MM, Espartero JL, Cert A. Antioxidant effect of phenolic compounds, alpha-tocopherol, and other minor components in virgin olive oil. J. Agric Food Chem. 2003 Nov 19;51(24):7170-5.
37. Psomiadou E, Tsimidou M. On the role of squalene in olive oil stability. J. Agric Food Chem. 1999 Oct;47(10):4025-32.
38. Psomiadou E, Tsimidou M. Stability of virgin olive oil. 1. Autoxidation studies. J. Agric Food Chem. 2002 Feb 13;50(4):716-21.
39. Psomiadou E, Tsimidou M. Stability of virgin olive oil. 2. Photo-oxidation studies. J. Agric Food Chem. 2002 Feb 13;50(4):722-7.
40. Tilvis RS, Miettinen TA. Absorption and metabolic fate of dietary 3H-squalene in the rat. Lipids. 1983 Mar;18(3):233-8.
41. Rao KS, Olson RE. The effect of exogenous cholesterol on the synthesis in vivo of cholesterol, ubiquinone, and squalene in rat liver. Biochem. Biophys. Res. Commun. 1967 Mar 21;26(6):668-73.
42. Strandberg TE, Tilvis RS, Miettinen TA. Squalene and sterol synthesis in isolated small-intestinal cells of the rat. Scand. J. Gastroenterol. 1981;16(6):801-10.
43. Tilvis RS, Miettinen TA. Dietary squalene increases tissue sterols and fecal bile acids in the rat. Lipids. 1983 Jan;18(1):32-6.
44. Strandberg TE, Tilvis RS, Miettinen TA. Variations of hepatic cholesterol precursors during altered flows of endogenous and exogenous squalene in the rat. Biochim. Biophys. Acta. 1989 Feb 6;1001(2):150-6.
45. Wiss O, Wiss V. The influence of fasting on the synthesis of cholesterol, squalene, fatty acids, and ubiquinones in liver, small intestine, and kidney of rats in vivo. Helv. Chim. Acta. 1977 Dec 14;60(8):2566-75.
46. Strandberg TE, Tilvis RS, Miettinen TA. Effects of cholestyramine and squalene feeding on hepatic and serum plant sterols in the rat. Lipids. 1989 Aug;24(8):705-8.
47. Tilvis RS, Miettinen TA. Fate of intravenously administered squalene in the rat. Biochim. Biophys. Acta. 1982 Aug 18;712(2):374-81.
48. Lewis RW. Effect of alimentation on human serum squalene levels. Lipids. 1976 Jun;11(6):430-3.
49. Gylling H, Miettinen TA. Postabsorptive metabolism of dietary squalene. Atherosclerosis. 1994 Apr;106(2):169-78.
50. Rajaratnam RA, Gylling H, Miettinen TA. Impaired postprandial clearance of squalene and apolipoprotein B-48 in post-menopausal women with coronary artery disease. Clin. Sci. (Lond). 1999 Aug;97(2):183-92.
51. Relas H, Gylling H, Miettinen TA. Dietary squalene increases cholesterol synthesis measured with serum non-cholesterol sterols after a single oral dose in humans. Atherosclerosis. 2000 Oct;152(2):377-83.
52. Relas H, Gylling H, Miettinen TA. Effect of stanol ester on postabsorptive squalene and retinyl palmitate. Metabolism. 2000 Apr;49(4):473-8.
53. Relas H, Gylling H, Miettinen TA. Fate of intravenously administered squalene and plant sterols in human subjects. J. Lipid Res. 2001 Jun;42(6):988-94.
54. Relas H, Gylling H, Rajaratnam RA, Miettinen TA. Postprandial retinyl palmitate and squalene metabolism is age dependent. J. Gerontol. A Biol. Sci. Med. Sci. 2000 Nov;55(11):B515-21.
55. Gylling H, Relas H, Miettinen TA. Postprandial vitamin A and squalene clearances and cholesterol synthesis off and on lovastatin treatment in type III hyperlipoproteinemia. Atherosclerosis. 1995 May;115(1):17-26.
56. Gylling H, Relas H, Miettinen HE, Radhakrishnan R, Miettinen TA. Delayed postprandial retinyl palmitate and squalene removal in a patient heterozygous for apolipoprotein A-IFIN mutation (Leu 159-->Arg) and low HDL cholesterol level without coronary artery disease. Atherosclerosis. 1996 Dec 20;127(2):239-43.
57. Hallikainen M, Vidgren H, Agren JJ, Kiviniemi V, Miettinen TA, Gylling H. Postprandial behavior of plasma squalene and non-cholesterol sterols in men with varying cholesterol absorption. Clin. Chim. Acta. 2006 Dec;374(1-2):63-8.
58. Liu GCK, Ahrens EH, Schreibman PH, Samuel P, McNamara DJ, Crouse JR. Measurement of cholesterol synthesis in man by isotope kinetics of squalene. Proc. Natl. Acad. Sci. 1975;72:4612-6.
59. Goodman DS. Squalene in Human and Rat Blood Plasma. J. Clin. Invest. 1964 Jul;43:1480-5.
60. Saudek CD, Frier BM, Liu GC. Plasma squalene: lipoprotein distribution and kinetic analysis. J. Lipid Res. 1978 Sep;19(7):827-35.
61. Miettinen TA, Vanhanen H. Serum concentration and metabolism of cholesterol during rapeseed oil and squalene feeding. Am. J. Clin. Nutr. 1994 Feb;59(2):356-63.
62. Rajaratnam RA, Gylling H, Miettinen TA. Serum squalene in postmenopausal women without and with coronary artery disease. Atherosclerosis. 1999 Sep;146(1):61-4.
63. Miettinen TA. Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J. Lipid Res. 1982 Mar;23(3):466-73.
64. Nissinen MJ, Gylling H, Miettinen TA. Effects of plant stanol esters supplied in a fat free milieu by pastilles on cholesterol metabolism in colectomized human subjects. Nutr. Metab. Cardiovasc. Dis. 2006 Sep;16(6):426-35.
65. Ketomaki A, Gylling H, Siimes MA, Vuorio A, Miettinen TA. Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia. Pediatr. Res. 2003 Apr;53(4):648-53.
66. Ketomaki A, Gylling H, Miettinen TA. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject. J. Lab. Clin. Med. 2004 Apr;143(4):255-62.
67. Copado MA, Ruiz-Gutierrez V, Rodriguez-Burgos A. Fatty acids and squalene carried by alpha fetoprotein, and fetal and adult serum albumin from chicken. Comparison with these from mammals. J. Protein. Chem. 1999 May;18(4):413-24.
68. Ruiz-Gutierrez V, Moreno R, Moreda W, Copado MA, Rodriguez-Burgos A. Detection of squalene in alpha-fetoprotein and fetal serum albumin from bovine. J. Protein Chem. 2001 Jan;20(1):19-23.
69. Frier BM, Saudek CD. Cholesterol metabolism in diabetes: the effect of insulin on the kinetics of plasma squalene. J. Clin. Endocrinol. Metab. 1979 Dec;49(6):824-9.
70. Nikkila K, Miettinen TA. Serum cholesterol precursors, cholestanol, and plant sterols in primary biliary cirrhosis. Scand. J. Gastroenterol. 1988 Oct;23(8):967-72.
71. Nestel PJ, Kudchodkar B. Plasma squalene as an index of cholesterol synthesis. Clin. Sci. Mol. Med. 1975 Dec;49(6):621-4.
72. Miettinen TA, Hallikainen M, Raitakari OT, Viikari J, Gylling H. Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study. Nutr. Metab. Cardiovasc. Dis. 2009 Jan 28.
73. Miettinen TA. Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. Life Sci. 1969 Jul 15;8(14):713-21.
74. Miettinen TA. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur. J. Clin. Invest. 1980 Feb;10(1):27-35.
75. Miettinen TA, Gylling H, Tuominen J, Simonen P, Koivisto V. Low synthesis and high absorption of cholesterol characterize type 1 diabetes. Diabetes Care. 2004 Jan;27(1):53-8.
76. Simonen PP, Gylling H, Miettinen TA. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes. Atherosclerosis. 2007 Sep;194(1):222-9.
77. Simonen P, Gylling H, Miettinen TA. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis. 2008 Apr;197(2):883-8.
78. Smahelova A, Hyspler R, Haas T. Relation of cholesterol metabolism and non-cholesterol sterols to insulin resistance. Physiol. Res. 2007;56(6):749-55.
79. Vuoristo M, Vaananen H, Miettinen TA. Cholesterol malabsorption in pancreatic insufficiency: effects of enzyme substitution. Gastroenterology. 1992 Feb;102(2):647-55.
80. Hirayama C, Yamanishi Y, Irisa T. Serum cholesterol and squalene in hepatocellular carcinoma. Clin. Chim. Acta. 1979 Jan 1;91(1):53-7.
81. Nosaka Y, Yamanishi Y, Hirayama C. Biliary squalene levels in hepatobiliary disease. Gastroenterol. Jpn. 1985 Aug;20(4):338-43.
82. Nikkila K, Riikonen S, Lindfors M, Miettinen TA. Serum squalene and noncholesterol sterols before and after delivery in normal and cholestatic pregnancy. J. Lipid Res. 1996 Dec;37(12):2687-95.
83. Koivisto PV, Miettinen TA. Increased amounts of cholesterol precursors in lipoproteins after ileal exclusion. Lipids. 1988 Oct;23(10):993-6.
84. Gylling H, Miettinen TA. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J. Lipid Res. 2002 Sep;43(9):1472-6.
85. Nikkila K, Hockerstedt K, Miettinen TA. Serum and hepatic cholestanol, squalene and noncholesterol sterols in man: a study on liver transplantation. Hepatology. 1992 May;15(5):863-70.
86. Miettinen TA, Tilvis R. Comparison of different components in the fractional conversion of mevalonate to cholesterol with cholesterol synthesis and serum methyl sterols. Scand. J. Clin. Lab. Invest. 1981 Sep;41(5):507-12.
87. Miettinen TA, Gylling H, Viikari J, Lehtimaki T, Raitakari OT. Synthesis and absorption of cholesterol in Finnish boys by serum non-cholesterol sterols: the cardiovascular risk in Young Finns Study. Atherosclerosis. 2008 Sep;200(1):177-83.
88. Tilvis R, Miettinen TA. Squalene, methyl sterol, and cholesterol levels in human organs. Postmortem analysis of their distributions. Arch. Pathol. Lab. Med. 1980 Jan;104(1):35-40.
89. Miettinen TA, Tilvis RS. Cholesterol synthesis and storage in adipose tissue. Int. J. Obes. 1981;5(6):613-8.
90. Tilvis RS, Kovanen PT, Miettinen TA. Release of newly synthesized squalene, methyl sterols and cholesterol from human adipocytes in the presence of lipoproteins. Scand. J. Clin. Lab. Invest. 1978 Feb;38(1):83-7.
91. Tilvis R, Kovanen PT, Miettinen TA. Metabolism of squalene in human fat cells. Demonstration of a two-pool system. J. Biol. Chem. 1982 Sep 10;257(17):10300-5.
92. Tilvis R, Miettinen TA. Effects of weight reduction on squalene, methyl sterols and cholesterol and on their synthesis in human adipose tissue. Eur. J. Clin. Invest. 1979 Apr;9(2 Pt 1):155-60.
93. Simonen P, Gylling H, Miettinen TA. Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes. Clin. Chim. Acta. 2002 Feb;316(1-2):55-61.
94. Yamanishi Y, Ikawa S, Hirayama C. Serum squalene levels in hepatobiliary diseases. Clin. Chim. Acta. 1978 Aug 15;88(1):105-10.
95. Miettinen TA, Gallin JI, O'Leary WM, Kaye D. Serum squalene and methyl sterols. N. Engl. J. Med. 1970 Nov 5;283(19):1054-5.
96. Tilvis RS, Aro J, Strandberg TE, Lempinen M, Miettinen TA. Lipid composition of bile and gallbladder mucosa in patients with acalculous cholesterolosis. Gastroenterology. 1982 Apr;82(4):607-15.
97. Antero Kesaniemi Y, Koskenvuo M, Vuoristo M, Miettinen TA. Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut. 1989 Dec;30(12):1750-6.
98. Kallio MJ, Siimes MA, Perheentupa J, Salmenpera L, Miettinen TA. Cholesterol and its precursors in human milk during prolonged exclusive breast-feeding. Am. J. Clin. Nutr. 1989 Oct;50(4):782-5.
99. Dempsey ME, McCoy KE, Baker HN, Dimitriadou-Vafiadou A, Lorsbach T, Howard JB. Large scale purification and structural characterization of squalene and sterol carrier protein. J. Biol. Chem. 1981 Feb 25;256(4):1867-73.
100. Ritter MC, Dempsey ME. Squalene and sterol carrier protein: structural properties, lipid-binding, and function in cholesterol biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 1973 Jan;70(1):265-9.
101. Johnson RC, Shah SN. Binding of squalene, lanosterol, desmosterol, and cholesterol to proteins in brain and liver 105,000 g supernatant fractions: evidence for specific binding sites. Lipids. 1976 Sep;11(9):645-51.
102. Zingg JM, Kempna P, Paris M, Reiter E, Villacorta L, Cipollone R, et al. Characterization of three human sec14p-like proteins: alpha-tocopherol transport activity and expression pattern in tissues. Biochimie. 2008 Nov-Dec;90(11-12):1703-15.
103. Habermehl D, Kempna P, Azzi A, Zingg JM. Recombinant SEC14-like proteins (TAP) possess GTPase activity. Biochem. Biophys. Res. Commun. 2005 Jan 7;326(1):254-9.
104. Paroli E. [Effect of beta-carotene and of squalene on analgesia and respiratory depression caused by morphine]. Boll. Soc. Ital. Biol. Sper. 1964 Oct 15;40(19):1204-7.
105. Matschiner JT, Amelotti JM, Doisy EA, Jr. Mechanism of the effect of retinoic acid and squalene on vitamin K deficiency in the rat. J. Nutr. 1967 Mar;91(3):303-6.
106. Yamaguchi T, Nakagawa M, Hidaka K, Yoshida T, Sasaki T, Akiyama S, et al. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system. Jpn. J. Cancer Res. 1985 Oct;76(10):1021-6.
107. Das B, Yeger H, Baruchel H, Freedman MH, Koren G, Baruchel S. In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity. implications in cancer chemotherapy. Eur. J. Cancer. 2003 Nov;39(17):2556-65.
108. Das B, Antoon R, Tsuchida R, Lotfi S, Morozova O, Farhat W, et al. Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. Neoplasia. 2008 Oct;10(10):1105-19.
109. Storm HM, Oh SY, Kimler BF, Norton S. Radioprotection of mice by dietary squalene. Lipids. 1993 Jun;28(6):555-9.
110. Senthilkumar S, Devaki T, Manohar BM, Babu MS. Effect of squalene on cyclophosphamide-induced toxicity. Clin. Chim. Acta. 2006 Feb;364(1-2):335-42.
111. Senthilkumar S, Yogeeta SK, Subashini R, Devaki T. Attenuation of cyclophosphamide induced toxicity by squalene in experimental rats. Chem. Biol. Interact. 2006 Apr 15;160(3):252-60.
112. Richter E, Schafer SG, Fichtl B. Stimulation of the faecal excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in rats by squalane. Xenobiotica. 1983 Jun;13(6):337-43.
113. de la Puerta R, Martinez-Dominguez E, Ruiz-Gutierrez V. Effect of minor components of virgin olive oil on topical antiinflammatory assays. Z. Naturforsch C. 2000 Sep-Oct;55(9-10):814-9.
114. Bullon P, Quiles JL, Morillo JM, Rubini C, Goteri G, Granados-Principal S, et al. Gingival vascular damage in atherosclerotic rabbits: Hydroxytyrosol and squalene benefits. Food Chem. Toxicol. 2009 Jun 21.
115. Channon HJ, Tristram GR. The effect of the administration of squalene and other hydrocarbons on cholesterol metabolism in the rat. Biochem. J. 1937 May;31(5):738-47.
116. Tomkins GM, Dauben WG, Sheppard H, Chaikoff IL. Squalene as a precursor of cholesterol in liver. J. Biol. Chem. 1953 Jun;202(2):487-9.
117. Eidinoff ML, Knoll JE, Marano BJ, Kvamme E, Rosenfeld RS, Hellman L. Cholesterol biosynthesis: studies related to the metabolic role of squalene. J. Clin. Invest. 1958 May;37(5):655-9.
118. Stefanovich V, Kajiyama G. Squalene and cholestanol in normal rabbit aorta. Atherosclerosis. 1970 May-Jun;11(3):401-3.
119. Ramsey RB, Aexel RT, Jain S, Nicholas HJ. Distribution of alkanes in normal and atherosclerotic rabbit aortas. Atherosclerosis. 1972 May-Jun;15(3):301-6.
120. Garbuzov AG, Pyatnitskii NN, Piskunov AK. Presence of squalene in human aorta. Fed. Proc. Transl. Suppl. 1966 May-Jun;25(3):463-4.
121. Brooks CJ, Harland WA, Steel G. Squalene, 26-hydroxycholesterol and 7-ketocholesterol in human atheromatous plaques. Biochim. Biophys. Acta. 1966 Dec 7;125(3):620-2.
122. Lewis RW. The squalene content of atheromatous plaques. A re-examination. Atherosclerosis. 1975 Nov-Dec;22(3):637-40.
123. Helske S, Miettinen T, Gylling H, Mayranpaa M, Lommi J, Turto H, et al. Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves. J. Lipid Res. 2008 Jul;49(7):1511-8.
124. Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J. Am. Coll. Cardiol. 2000 Apr;35(5):1185-91.
125. Vuorio AF, Miettinen TA, Turtola H, Oksanen H, Gylling H. Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns. J. Lab. Clin. Med. 2002 Jul;140(1):35-42.
126. Kritchevsky D, Moyer AW, Tesar WC. Squalene feeding in experimental atherosclerosis. Arch. Biochem. Biophys. 1953 May;44(1):241.
127. Kritchevsky D, Moyer AW, Tesar WC, Logan JB, Brown RA, Richmond G. Squalene feeding in experimental atherosclerosis. Circ. Res. 1954 Jul;2(4):340-3.
128. Ostlund RE, Jr., Racette SB, Stenson WF. Effects of trace components of dietary fat on cholesterol metabolism: phytosterols, oxysterols, and squalene. Nutr. Rev. 2002 Nov;60(11):349-59.
129. Strandberg TE, Tilvis RS, Miettinen TA. Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J. Lipid Res. 1990 Sep;31(9):1637-43.
130. Neuvonen PJ, Kuusisto P, Manninen V, Vapaatalo H, Miettinen TA. The mechanism of the hypocholesterolaemic effect of activated charcoal. Eur. J. Clin. Invest. 1989 Jun;19(3):251-4.
131. Richter E, Schafer SG. The effect of squalane on the absorption of dietary cholesterol by the rat. Res Exp Med (Berl). 1982;180(2):189-91.
132. Scolastici C, Ong TP, Moreno FS. Squalene does not exhibit a chemopreventive activity and increases plasma cholesterol in a Wistar rat hepatocarcinogenesis model. Nutr. Cancer. 2004;50(1):101-9.
133. Zhang Z, Yeung WK, Huang Y, Chen ZY. Effect of squalene and shark liver oil on serum cholesterol level in hamsters. Int. J. Food Sci. Nutr. 2002 Sep;53(5):411-8.
134. Guillen N, Acin S, Navarro MA, Perona JS, Arbones-Mainar JM, Arnal C, et al. Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis. 2008 Mar;197(1):72-83.
135. Sabeena Farvin KH, Anandan R, Kumar SH, Shiny KS, Sankar TV, Thankappan TK. Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol. Res. 2004 Sep;50(3):231-6.
136. Farvin KH, Anandan R, Kumar SH, Shiny KS, Mathew S, Sankar TV, et al. Cardioprotective effect of squalene on lipid profile in isoprenaline-induced myocardial infarction in rats. J. Med. Food. 2006 Winter;9(4):531-6.
137. Liu Y, Xu X, Bi D, Wang X, Zhang X, Dai H, et al. Influence of squalene feeding on plasma leptin, testosterone & blood pressure in rats. Indian J. Med. Res. 2009 Feb;129(2):150-3.
138. van Rooyen J, Esterhuyse AJ, Engelbrecht AM, du Toit EF. Health benefits of a natural carotenoid rich oil: a proposed mechanism of protection against ischaemia/ reperfusion injury. Asia Pac. J. Clin. Nutr. 2008;17 Suppl 1:316-9.
139. Berger A, Gremaud G, Baumgartner M, Rein D, Monnard I, Kratky E, et al. Cholesterol-lowering properties of amaranth grain and oil in hamsters. Int. J. Vitam. Nutr. Res. 2003 Feb;73(1):39-47.
140. Martirosyan DM, Miroshnichenko LA, Kulakova SN, Pogojeva AV, Zoloedov VI. Amaranth oil application for coronary heart disease and hypertension. Lipids Health Dis. 2007;6:1.
141. Shin DH, Heo HJ, Lee YJ, Kim HK. Amaranth squalene reduces serum and liver lipid levels in rats fed a cholesterol diet. Br. J. Biomed. Sci. 2004;61(1):11-4.
142. Chan P, Tomlinson B, Lee CB, Lee YS. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia. J. Clin. Pharmacol. 1996 May;36(5):422-7.
143. Seiki S, Frishman WH. Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia. Cardiol. Rev. 2009 Mar-Apr;17(2):70-6.
144. Vanhanen H, Miettinen TA. Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia. Eur. J. Clin. Pharmacol. 1992;42(2):127-30.
145. Vanhanen HT, Blomqvist S, Ehnholm C, Hyvonen M, Jauhiainen M, Torstila I, et al. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J. Lipid Res. 1993 Sep;34(9):1535-44.
146. Fujita H, Shimotsuura S, Yanagisawa A, Morita I, Murota S, Ishikawa K. Simvastatin enhanced sodium nitroprusside-induced apoptosis of smooth muscle cells. An involvement of geranylgeraniol. Atherosclerosis. 2000 Feb;148(2):309-15.
147. Rogler G, Lackner KJ, Schmitz G. Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro. Am. J. Cardiol. 1995 Jul 13;76(2):114A-6A.
148. Ikeda U, Shimpo M, Ohki R, Inaba H, Takahashi M, Yamamoto K, et al. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells. Hypertension. 2000 Sep;36(3):325-9.
149. Escrich E, Moral R, Grau L, Costa I, Solanas M. Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol. Nutr. Food Res. 2007 Oct;51(10):1279-92.
150. Owen RW, Haubner R, Wurtele G, Hull E, Spiegelhalder B, Bartsch H. Olives and olive oil in cancer prevention. Eur. J. Cancer Prev. 2004 Aug;13(4):319-26.
151. Newmark HL. Squalene, olive oil, and cancer risk: a review and hypothesis. Cancer Epidemiol. Biomarkers Prev. 1997 Dec;6(12):1101-3.
152. Rao CV, Newmark HL, Reddy BS. Chemopreventive effect of squalene on colon cancer. Carcinogenesis. 1998 Feb;19(2):287-90.
153. Hashim YZ, Eng M, Gill CI, McGlynn H, Rowland IR. Components of olive oil and chemoprevention of colorectal cancer. Nutr. Rev. 2005 Nov;63(11):374-86.
154. Smith TJ, Yang GY, Seril DN, Liao J, Kim S. Inhibition of 4-(methylnitrosamino) - 1 - (3 - pyridyl) - 1 - butanone - induced lung tumorigenesis by dietary olive oil and squalene. Carcinogenesis. 1998 Apr;19(4):703-6.
155. Newmark HL. Squalene, olive oil, and cancer risk. Review and hypothesis. Ann. N. Y. Acad. Sci. 1999;889:193-203.
156. Sotiroudis TG, Kyrtopoulos SA. Anticarcinogenic compounds of olive oil and related biomarkers. Eur. J. Nutr. 2008 May;47 Suppl 2:69-72.
157. Saenz MT, Garcia MD, Ahumada MC, Ruiz V. Cytostatic activity of some compounds from the unsaponifiable fraction obtained from virgin olive oil. Farmaco. 1998 Jun 30;53(6):448-9.
158. Katdare M, Singhal H, Newmark H, Osborne MP, Telang NT. Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors. Cancer Lett. 1997 Jan 1;111(1-2):141-7.
159. Desai KN, Wei H, Lamartiniere CA. The preventive and therapeutic potential of the squalene-containing compound, Roidex, on tumor promotion and regression. Cancer Lett. 1996 Mar 19;101(1):93-6.
160. Murakoshi M, Nishino H, Tokuda H, Iwashima A, Okuzumi J, Kitano H, et al. Inhibition by squalene of the tumor-promoting activity of 12-O-tetradecanoylphorbol-13-acetate in mouse-skin carcinogenesis. Int. J. Cancer. 1992 Dec 2;52(6):950-2.
161. Nakagawa M, Yamaguchi T, Fukawa H, Ogata J, Komiyama S, Akiyama S, et al. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor. Jpn. J. Cancer Res. 1985 Apr;76(4):315-20.
162. Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis. 2000 Mar;21(3):525-30.
163. Ito M, Iizuka H, Masuno T, Yasunami R, Ogura T, Yamamura Y, et al. Killing of tumor cells in vitro by macrophages from mice given injections of squalene-treated cell wall skeleton of Nocardia rubra. Cancer Res. 1981 Jul;41(7):2925-30.
164. Xing Y, Xu Y, Chen Y, Jeffrey PD, Chao Y, Lin Z, et al. Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. Cell. 2006 Oct 20;127(2):341-53.
165. Souto ML, Manriquez CP, Norte M, Leira F, Fernandez JJ. The inhibitory effects of squalene-derived triterpenes on protein phosphatase PP2A. Bioorg. Med. Chem. Lett. 2003 Apr 7;13(7):1261-4.
166. Huang ZR, Lin YK, Fang JY. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules. 2009;14(1):540-54.
167. Smith KR, Thiboutot DM. Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe? J. Lipid Res. 2008 Feb;49(2):271-81.
168. Guldur T, Bayraktar N, Kaynar O, Beker G, Kocer M, Ozcan H. Excretion rate and composition of skin surface lipids on the foreheads of adult males with type IV hyperlipoproteinemia. J. Basic Clin. Physiol. Pharmacol. 2007;18(1):21-35.
169. Thiele JJ, Weber SU, Packer L. Sebaceous gland secretion is a major physiologic route of vitamin E delivery to skin. J. Invest. Dermatol. 1999 Dec;113(6):1006-10.
170. Thiele JJ, Schroeter C, Hsieh SN, Podda M, Packer L. The antioxidant network of the stratum corneum. Curr. Probl. Dermatol. 2001;29:26-42.
171. Passi S, De Pita O, Grandinetti M, Simotti C, Littarru GP. The combined use of oral and topical lipophilic antioxidants increases their levels both in sebum and stratum corneum. Biofactors. 2003;18(1-4):289-97.
172. Cho S, Choi CW, Lee DH, Won CH, Kim SM, Lee S, et al. High-dose squalene ingestion increases type I procollagen and decreases ultraviolet-induced DNA damage in human skin in vivo but is associated with transient adverse effects. Clin. Exp. Dermatol. 2009 Jun;34(4):500-8.
173. Hayakawa R, Ueda H, Nozaki T, Izawa Y, Yokotake J, Yazaki K, et al. Effects of combination treatment with vitamins E and C on chloasma and pigmented contact dermatitis. A double blind controlled clinical trial. Acta Vitaminol. Enzymol. 1981;3(1):31-8.
174. Ohsawa K, Watanabe T, Matsukawa R, Yoshimura Y, Imaeda K. The possible role of squalene and its peroxide of the sebum in the occurrence of sunburn and protection from the damage caused by U.V. irradiation. J. Toxicol. Sci. 1984 May;9(2):151-9.
175. Picardo M, Zompetta C, De Luca C, Cirone M, Faggioni A, Nazzaro-Porro M, et al. Role of skin surface lipids in UV-induced epidermal cell changes. Arch. Dermatol. Res. 1991;283(3):191-7.
176. Ottaviani M, Alestas T, Flori E, Mastrofrancesco A, Zouboulis CC, Picardo M. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J. Invest. Dermatol. 2006 Nov;126(11):2430-7.
177. Ryu A, Arakane K, Koide C, Arai H, Nagano T. Squalene as a target molecule in skin hyperpigmentation caused by singlet oxygen. Biol. Pharm. Bull. 2009 Sep;32(9):1504-9.
178. Picardo M, Zompetta C, De Luca C, Amantea A, Faggioni A, Nazzaro-Porro M, et al. Squalene peroxides may contribute to ultraviolet light-induced immunological effects. Photodermatol. Photoimmunol. Photomed. 1991 Jun;8(3):105-10.
179. Kohno Y, Egawa Y, Itoh S, Nagaoka S, Takahashi M, Mukai K. Kinetic study of quenching reaction of singlet oxygen and scavenging reaction of free radical by squalene in n-butanol. Biochim. Biophys. Acta. 1995 Apr 28;1256(1):52-6.
180. Ekanayake Mudiyanselage S, Hamburger M, Elsner P, Thiele JJ. Ultraviolet a induces generation of squalene monohydroperoxide isomers in human sebum and skin surface lipids in vitro and in vivo. J. Invest. Dermatol. 2003 Jun;120(6):915-22.
181. Arakane K, Ryu A, Hayashi C, Masunaga T, Shinmoto K, Mashiko S, et al. Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation. Biochem. Biophys. Res. Commun. 1996 Jun 25;223(3):578-82.
182. Cornelius CE, 3rd, Ludwig GD. Red fluorescence of comedones: production of porphyrins by Corynebacterium acnes. J. Invest. Dermatol. 1967 Oct;49(4):368-70.
183. Johnsson A, Kjeldstad B, Melo TB. Fluorescence from pilosebaceous follicles. Arch. Dermatol. Res. 1987;279(3):190-3.
184. Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br. J. Dermatol. 1983 Aug;109(2):191-8.
185. Saint-Leger D, Bague A, Lefebvre E, Cohen E, Chivot M. A possible role for squalene in the pathogenesis of acne. II. In vivo study of squalene oxides in skin surface and intra-comedonal lipids of acne patients. Br. J. Dermatol. 1986 May;114(5):543-52.
186. Saint-Leger D, Bague A, Cohen E, Chivot M. A possible role for squalene in the pathogenesis of acne. I. In vitro study of squalene oxidation. Br. J. Dermatol. 1986 May;114(5):535-42.
187. Chiba K, Yoshizawa K, Makino I, Kawakami K, Onoue M. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J. Toxicol. Sci. 2000 May;25(2):77-83.
188. Borelli C, Merk K, Schaller M, Jacob K, Vogeser M, Weindl G, et al. In vivo porphyrin production by P. acnes in untreated acne patients and its modulation by acne treatment. Acta Derm. Venereol. 2006;86(4):316-9.
189. Chiba K, Sone T, Kawakami K, Onoue M. Skin roughness and wrinkle formation induced by repeated application of squalene-monohydroperoxide to the hairless mouse. Exp. Dermatol. 1999 Dec;8(6):471-9.
190. Chiba K, Kawakami K, Sone T, Onoue M. Characteristics of skin wrinkling and dermal changes induced by repeated application of squalene monohydroperoxide to hairless mouse skin. Skin Pharmacol Appl. Skin. Physiol. 2003 Jul-Aug;16(4):242-51.
191. Uchino T, Tokunaga H, Onodera H, Ando M. Effect of squalene monohydroperoxide on cytotoxicity and cytokine release in a three-dimensional human skin model and human epidermal keratinocytes. Biol. Pharm. Bull. 2002 May;25(5):605-10.
192. Chiba K, Yoshizawa K, Makino I, Kawakami K, Onoue M. Changes in the levels of glutathione after cellular and cutaneous damage induced by squalene monohydroperoxide. J. Biochem. Mol. Toxicol. 2001;15(3):150-8.
193. Viola P, Viola M. Virgin olive oil as a fundamental nutritional component and skin protector. Clin. Dermatol. 2009 Mar-Apr;27(2):159-65.
194. Ohkuma T, Otagiri K, Tanaka S, Ikekawa T. Intensification of host's immunity by squalene in sarcoma 180 bearing ICR mice. J. Pharmacobiodyn. 1983 Feb;6(2):148-51.
195. McKee AS, Munks MW, Marrack P. How do adjuvants work? Important considerations for new generation adjuvants. Immunity. 2007 Nov;27(5):687-90.
196. Valensi JP, Carlson JR, Van Nest GA. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol. 1994 Nov 1;153(9):4029-39.
197. Van der Meide PH, Schellekens H. Cytokines and the immune response. Biotherapy. 1996;8(3-4):243-9.
198. Allison AC. Squalene and squalane emulsions as adjuvants. Methods. 1999;19:87-93
199. Messeri G, Billi D, Curiel P, Mello G. Amniotic fluid squalene and gestational age. Clin. Chem. 1982 Aug;28(8):1810-1.
200. Tan MA, Takayama H, Aimi N, Kitajima M, Franzblau SG, Nonato MG. Antitubercular triterpenes and phytosterols from Pandanus tectorius Soland. var. laevis. Nat. Med. (Tokyo). 2008 Apr;62(2):232-5.
201. Couvreur P, Stella B, Reddy LH, Hillaireau H, Dubernet C, Desmaele D, et al. Squalenoyl nanomedicines as potential therapeutics. Nano Lett. 2006 Nov;6(11):2544-8.
202. Sarpietro MG, Micieli D, Rocco F, Ceruti M, Castelli F. Conjugation of squalene to acyclovir improves the affinity for biomembrane models. Int. J. Pharm. 2009 Dec 1;382(1-2):73-9.
203. Zhang W, Zhang X, Bi D, Wang X, Cai Y, Dai H, et al. Feeding with supplemental squalene enhances the productive performance in boars. Anim. Reprod. Sci. 2008 Mar 3;104(2-4):445-9.
204. Aguilera Y, Dorado ME, Prada FA, Martinez JJ, Quesada A, Ruiz-Gutierrez V. The protective role of squalene in alcohol damage in the chick embryo retina. Exp. Eye Res. 2005 Apr;80(4):535-43.
205. Bartlett JG. Lipoid pneumonia. Text book of pulmonary diseases. Boston: Little Brown & Co; 1989. p. 557-63.
206. Asnis DS, Saltzman HP, Melchert A. Shark oil pneumonia. An overlooked entity. Chest. 1993 Mar;103(3):976-7.
207. Lee JY, Lee KS, Kim TS, Yoon HK, Han BK, Han J, et al. Squalene-induced extrinsic lipoid pneumonia: serial radiologic findings in nine patients. J. Comput. Assist. Tomogr. 1999 Sep-Oct;23(5):730-5.
208. Lee JS, Im JG, Song KS, Seo JB, Lim TH. Exogenous lipoid pneumonia: high-resolution CT findings. Eur. Radiol. 1999;9(2):287-91.
209. Pinkerton H. The reaction to oils and fats in the lung. Arch. Pathol. 1928;5:380-401.
210. Gajkowska B, Smialek M, Ostrowski RP, Piotrowski P, Frontczak-Baniewicz M. The experimental squalene encephaloneuropathy in the rat. Exp. Toxicol. Pathol. 1999 Jan;51(1):75-80.
211. Smialek M, Gajkowska B, Ostrowski RP, Piotrowski P. Experimental squalene encephaloneuropathy in the rat. Folia Neuropathol. 1997;35(4):262-4.
212. Asa PB, Cao Y, Garry RF. Antibodies to squalene in Gulf War syndrome. Exp. Mol. Pathol. 2000 Feb;68(1):55-64.
213. Matyas GR, Rao M, Alving CR. Induction and detection of antibodies to squalene. II. Optimization of the assay for murine antibodies. J. Immunol. Methods. 2002 Sep 15;267(2):119-29.
214. Phillips CJ, Matyas GR, Hansen CJ, Alving CR, Smith TC, Ryan MA. Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. Vaccine. 2009 Jun 12;27(29):3921-6.
215. Spanggord RJ, Sun M, Lim P, Ellis WY. Enhancement of an analytical method for the determination of squalene in anthrax vaccine adsorbed formulations. J. Pharm. Biomed. Anal. 2006 Oct 11;42(4):494-9.
216. Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine. 2001 Mar 21;19(17-19):2673-80.
217. Matyas GR, Rao M, Pittman PR, Burge R, Robbins IE, Wassef NM, et al. Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice. J. Immunol. Methods. 2004 Mar;286(1-2):47-67.